Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

NCT00242229 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: DVS-233 SR

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer